Increasing number of people are suffering from chronic pain and are addicted to opioid analgesics. Hence to limit the consumption of these drugs the demand of spinal cord stimulators is increasing. According to a study presented at North American Neuromodulation Society, spinal cord stimulators can reduce the use of opioid analgesics. With technological advancements, new treatment options are also being developed. For instance, a pain-blocking device that is safe for full body MRI was introduced by Virginia Spine Institute. This device showcased some advancement in technology. More such devices and treatments are being introduced for patients with chronic pain and spinal diseases. However, the high cost of spinal cord stimulators remains the major constraint.
According to the latest study by Future Market Insights (FMI), Europe and North America are the largest markets for spinal cord stimulators. While Europe and the U.S. account for 85% of global spinal cord stimulator market. However, the introduction of new and affordable devices are expected create an opportunity for spinal cord stimulators in emerging economies. The rechargeable spinal cord stimulators are expected to hold 70% value share of global spinal cord stimulator market by the end of 2027. These stimulators are also anticipated to register 7.2% CAGR in terms of value, while in terms of volume it is expected to increase to 7.5% CAGR during 2017-2027.
Product innovation to result in growing demand for spinal cord stimulators
In a new study, researchers used electrical stimulation on spinal cord combined with intense physical therapy. This led to the movement in paralyzed legs and made the patient stand for the first time in three years. After the surgery, the patient also received physical therapy. According to the researchers, the combination of technology and physical therapy may help patients with spinal cord injuries and spinal disease.
In electrical stimulation, the electrode is connected to a computer-controlled device under the skin. The device sends an electrical current to the spinal cord, which enables the patient to create movement. This device has received an approval from the U.S. Food and Drug Administration for off-label use. Hence, the epidural stimulation therapy may be beneficial for the people suffering due to spinal cord injury.
Artificial Intelligence (AI) software can help stroke and spinal injury patients to walk again. The researchers developed a robotic harness that uses cables to control upward and forward force, helping a person to walk forward, backward and sideways. This was controlled by software that customized the force experienced by patient depending on the specific problem. To offer customized experience, the system was depended on artificial neural network, where artificial neurons work together to solve a problem. This is an AI technique that imitates the human brain. As the neural network learns the pattern best for computing solutions.
The next generation spinal cord stimulators are being developed with cutting-edge technology, and these stimulators are lighter, compact, and highly efficient in patient care. Spinal cord stimulator developers are also focusing on innovation and introducing new products. For instance, an advanced stimulation technology was recently introduced by St Jude Medical for the treatment of spinal cord.